168 related articles for article (PubMed ID: 38096913)
21. Exploring Symptom Fluctuations and Triggers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Using Novel Patient-Centred N-of-1 Observational Designs: A Protocol for a Feasibility and Acceptability Study.
McDonald S; Tan SX; Banu S; van Driel M; McGree JM; Mitchell G; Nikles J
Patient; 2022 Mar; 15(2):197-206. PubMed ID: 34368926
[TBL] [Abstract][Full Text] [Related]
22. Myalgic encephalomyelitis/chronic fatigue syndrome and the biopsychosocial model: a review of patient harm and distress in the medical encounter.
Geraghty KJ; Blease C
Disabil Rehabil; 2019 Dec; 41(25):3092-3102. PubMed ID: 29929450
[No Abstract] [Full Text] [Related]
23. Diagnosis and Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Smith MEB; Nelson HD; Haney E; Pappas M; Daeges M; Wasson N; McDonagh M
Evid Rep Technol Assess (Full Rep); 2014 Dec; (219):1-433. PubMed ID: 30313001
[TBL] [Abstract][Full Text] [Related]
24. The relationship between prior psychiatric disorder and chronic fatigue: evidence from a national birth cohort study.
Harvey SB; Wadsworth M; Wessely S; Hotopf M
Psychol Med; 2008 Jul; 38(7):933-40. PubMed ID: 17976252
[TBL] [Abstract][Full Text] [Related]
25. A Literature Review of GP Knowledge and Understanding of ME/CFS: A Report from the Socioeconomic Working Group of the European Network on ME/CFS (EUROMENE).
Pheby DFH; Araja D; Berkis U; Brenna E; Cullinan J; de Korwin JD; Gitto L; Hughes DA; Hunter RM; Trepel D; Wang-Steverding X
Medicina (Kaunas); 2020 Dec; 57(1):. PubMed ID: 33374291
[No Abstract] [Full Text] [Related]
26. Are Circulating Fibroblast Growth Factor 21 and N-Terminal Prohormone of Brain Natriuretic Peptide Promising Novel Biomarkers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
Domingo JC; Cordobilla B; Ferrer R; Giralt M; Alegre-Martín J; Castro-Marrero J
Antioxid Redox Signal; 2021 Jun; 34(18):1420-1427. PubMed ID: 33353469
[TBL] [Abstract][Full Text] [Related]
27. What matters to children with CFS/ME? A conceptual model as the first stage in developing a PROM.
Parslow R; Patel A; Beasant L; Haywood K; Johnson D; Crawley E
Arch Dis Child; 2015 Dec; 100(12):1141-7. PubMed ID: 26453575
[TBL] [Abstract][Full Text] [Related]
28. Experiences of general practitioner continuity among women with chronic fatigue syndrome/myalgic encephalomyelitis: a cross-sectional study.
Hansen AH; Lian OS
BMC Health Serv Res; 2016 Nov; 16(1):650. PubMed ID: 27842587
[TBL] [Abstract][Full Text] [Related]
29. Experiences of daily activity in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) and their implications for rehabilitation programmes.
Pemberton S; Cox DL
Disabil Rehabil; 2014; 36(21):1790-7. PubMed ID: 24369769
[TBL] [Abstract][Full Text] [Related]
30. How do women with chronic fatigue syndrome/myalgic encephalomyelitis rate quality and coordination of healthcare services? A cross-sectional study.
Hansen AH; Lian OS
BMJ Open; 2016 Apr; 6(4):e010277. PubMed ID: 27044578
[TBL] [Abstract][Full Text] [Related]
31. Recruiting Adolescents With Chronic Fatigue Syndrome/Myalgic Encephalomyelitis to Internet-Delivered Therapy: Internal Pilot Within a Randomized Controlled Trial.
Anderson E; Parslow R; Hollingworth W; Mills N; Beasant L; Gaunt D; Metcalfe C; Kessler D; Macleod J; Pywell S; Pitts K; Price S; Stallard P; Knoop H; Van de Putte E; Nijhof S; Bleijenberg G; Crawley E
J Med Internet Res; 2020 Aug; 22(8):e17768. PubMed ID: 32784188
[TBL] [Abstract][Full Text] [Related]
32. Impact of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) on the quality of life of people with ME/CFS and their partners and family members: an online cross-sectional survey.
Vyas J; Muirhead N; Singh R; Ephgrave R; Finlay AY
BMJ Open; 2022 May; 12(5):e058128. PubMed ID: 35501074
[TBL] [Abstract][Full Text] [Related]
33. [Post-COVID syndrome with fatigue and exercise intolerance: myalgic encephalomyelitis/chronic fatigue syndrome].
Renz-Polster H; Scheibenbogen C
Inn Med (Heidelb); 2022 Aug; 63(8):830-839. PubMed ID: 35925074
[TBL] [Abstract][Full Text] [Related]
34. [Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Who Have Already Visited Some Medical Institutions: The Points of Diagnosis and Treatment].
Shimomura T
Brain Nerve; 2022 May; 74(5):660-667. PubMed ID: 35589661
[TBL] [Abstract][Full Text] [Related]
35. 'Betwixt and between'; liminality in recovery stories from people with myalgic encephalomyelitis (ME) or chronic fatigue syndrome (CFS).
Brown B; Huszar K; Chapman R
Sociol Health Illn; 2017 Jun; 39(5):696-710. PubMed ID: 28239872
[TBL] [Abstract][Full Text] [Related]
36. Medical School Education on Myalgic Encephalomyelitis.
Muirhead N; Muirhead J; Lavery G; Marsh B
Medicina (Kaunas); 2021 May; 57(6):. PubMed ID: 34071264
[No Abstract] [Full Text] [Related]
37. A critical analysis of the proposal of the Institute of Medicine to replace myalgic encephalomyelitis and chronic fatigue syndrome by a new diagnostic entity called systemic exertion intolerance disease.
Twisk FN
Curr Med Res Opin; 2015; 31(7):1333-47. PubMed ID: 25912615
[TBL] [Abstract][Full Text] [Related]
38. 'A life I can cope with'. An alternative model of cognitive behavioural therapy (CBT) for CFS/ME.
Clark C; Holttum S
Health Expect; 2022 Feb; 25(1):91-102. PubMed ID: 34472690
[TBL] [Abstract][Full Text] [Related]
39. The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome.
Murdock KW; Wang XS; Shi Q; Cleeland CS; Fagundes CP; Vernon SD
Qual Life Res; 2017 Apr; 26(4):913-921. PubMed ID: 27600520
[TBL] [Abstract][Full Text] [Related]
40. Comparative Survey of People with ME/CFS in Italy, Latvia, and the UK: A Report on Behalf of the Socioeconomics Working Group of the European ME/CFS Research Network (EUROMENE).
Brenna E; Araja D; Pheby DFH
Medicina (Kaunas); 2021 Mar; 57(3):. PubMed ID: 33806902
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
